Medical News

RSS

NIDA supports Omeros' Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.

28 Jan 2010

Life Spine's DYNA-LINK Spinal System and PRESIDIO Spinal Plating System receive FDA marketing clearance

Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to both the DYNA-LINK Spinal System and the PRESIDIO Spinal Plating System.

28 Jan 2010

Consumer survey results indicate cosmetic surgery is not taboo anymore

Cosmetic surgery is everywhere these days: TV, magazines, the Internet and more. And according to new data, society is indeed more comfortable talking about cosmetic surgery than ever before.

28 Jan 2010

EnteroMedics to submit an IDE application for next-generation Maestro RC System

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company’s EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.

28 Jan 2010

Excelsior Medical donates medical supplies to support Haiti earthquake relief effort

Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it is donating medical supplies to support the Haiti earthquake relief effort.

28 Jan 2010

Merck’s sales representatives ranked second by cardiologists

According to SDI’s recently released 2009 Ranking Tables Study, Merck’s sales representatives were ranked second by cardiologists, a noteworthy increase from sixth place in 2008. Pfizer was ranked first by cardiologists. Schering-Plough, AstraZeneca, and Novartis rounded out the top five, finishing third, fourth, and fifth, respectively.

28 Jan 2010

Most Britons not aware of the dangers of alcohol misuse

A government-funded advertising campaign launching today, backed by Cancer Research UK and other major health charities, aims to raise awareness of the unseen health damage caused by regular alcohol misuse.

28 Jan 2010

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.

28 Jan 2010

Kensey Nash announces financial results for second quarter of fiscal year 2010

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its three and six months ended December 31, 2009.

28 Jan 2010

Neovasc to fund proceeds of its non-brokered private placement for COSIRA trial

Neovasc Inc. today announced that it has completed the first tranche of a previously announced non-brokered private placement of approximately 7.4 million units at the price of $0.27 per unit for aggregate gross proceeds of up to $2.0 million.

28 Jan 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Celgene reports total revenue of $758M for fourth-quarter of 2009

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.

28 Jan 2010

Procter & Gamble reports increased net sales for October - December quarter

The Procter & Gamble Company delivered net sales growth of six percent for the October - December quarter to $21.0 billion. Organic sales grew five percent which was at the top of the Company's guidance range.

28 Jan 2010

Cenduit announces strategic business alliance with invivodata

Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).

28 Jan 2010

NBTY announces record results for fiscal first quarter

NBTY, Inc. (NYSE: NTY), a leading global manufacturer and marketer of nutritional supplements, today announced record results for the fiscal first quarter ended December 31, 2009.

28 Jan 2010

Chattem reports results for the year and fiscal fourth-quarter ended November 30, 2009

Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced results for the year and fiscal fourth quarter ended November 30, 2009.

28 Jan 2010

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

Idera Pharmaceuticals, Inc. today announced initiation of a Phase 1 clinical trial of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9.

28 Jan 2010

ACM Global Central Laboratory launches enhanced version of its proprietary LabStar system

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, has launched an enhanced version of its proprietary LabStarSM system, which captures all clinical trial testing data in a single location for easy access and comprehensive reporting.

28 Jan 2010

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.

28 Jan 2010

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Since the beginning of Operations Iraqi Freedom and Enduring Freedom, there have been nearly 36,000 battle- injured warriors, of which approximately 82 percent suffer extremity trauma. Many of these injuries are complicated by the effects of improvised explosive devices which cause injury patterns distinct from civilian trauma. Traditional wound-management guidelines simply fall short.

28 Jan 2010

Medical News

NIDA supports Omeros' Addiction program

Life Spine's DYNA-LINK Spinal System and PRESIDIO Spinal Plating System receive FDA marketing clearance

Consumer survey results indicate cosmetic surgery is not taboo anymore

EnteroMedics to submit an IDE application for next-generation Maestro RC System

Excelsior Medical donates medical supplies to support Haiti earthquake relief effort

Merck’s sales representatives ranked second by cardiologists

Most Britons not aware of the dangers of alcohol misuse

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

Kensey Nash announces financial results for second quarter of fiscal year 2010

Neovasc to fund proceeds of its non-brokered private placement for COSIRA trial

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Celgene reports total revenue of $758M for fourth-quarter of 2009

Procter & Gamble reports increased net sales for October - December quarter

Cenduit announces strategic business alliance with invivodata

NBTY announces record results for fiscal first quarter

Chattem reports results for the year and fiscal fourth-quarter ended November 30, 2009

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

ACM Global Central Laboratory launches enhanced version of its proprietary LabStar system

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News